Our studies clearly demonstrate that an elevation in VEGF may result in deleterious consequences in diabetic nephropathy, primarily by overactivation of the VEGFR2 pathway in the setting of endothelial dysfunction. This evidence concerns the gene VEGFA and endothelial dysfunction.